SCNI

SCINAI IMMUNOTHERAPEUTICS LT

SCNI·09073Q303·US·ADR·Healthcare - Biotechnology

SCNI (SCINAI IMMUNOTHERAPEUTICS LT) is held by 9 institutional investors as of Q2 2026. Largest holders: CITADEL ADVISORS LLC ($15,726), XTX Topco Ltd ($4,235), RHUMBLINE ADVISERS ($3,417). Net institutional sentiment: Bullish.

9
Holders
(1 Elite)
$27,442
Total Value
88% (8)
Consensus
7 buying - 1 selling
13F: Insider & Congress: Updated regularly
SCNI

Smart Money Verdict

View all
Loading verdict
Held by 9 funds
1 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for SCNI.

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
62,257$15,7260.0%+13.44%
28
Decreased
16,764(-30.3%)$4,2350.0%-59.69%
0
Increased
13,513(+619.5%)$3,4170.0%-50.12%
15
New
12,035$3,0400.0%+13.44%
20
Increased
3,955(+330.4%)$1,0010.0%-20.82%
12
Unchanged
58$150.0%-89.68%
0
New
19,485$50.0%+13.44%
15
New
12,088$30.0%+13.44%
17
New
815$00.0%+13.44%
17
SCNISCNISCINAI IMMUNOTHERAPEUTICS LT

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used